PYC Therapeutics Investor Relations Material
Latest events
Q2 2025
PYC Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PYC Therapeutics Limited
Access all reports
PYC Therapeutics Limited is an Australia-based biotechnology company focused on developing RNA-based therapies to treat genetic diseases. The company specializes in precision medicine, leveraging its RNA therapeutic platform to design and deliver drugs targeting the root causes of genetic disorders. PYC Therapeutics is involved in preclinical and clinical development, with a focus on rare inherited diseases, particularly those affecting vision and the central nervous system. The company is headquartered in Perth, Western Australia, and its shares are listed on the ASX.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
PYC
Country
🇦🇺 Australia